-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/27 cls Gilead Sciences Inc. (NASDAQ:GILD) RBC Capital Markets Michael Yee Price target Market outperform 3% $48.72 Yee raised his …
Published on 1/30/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/20 cls Amgen Inc. (NASDAQ:AMGN) Baird Christopher Raymond Price target Market outperform 3% $69.57 Raymond raised his target to $75…
Published on 1/23/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/13 cls Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) Baird Thomas Russo Price target Market outperform 56% $12.37 Leerink Howard …
Published on 1/16/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/6 cls Aveo Pharmaceuticals Inc. (NASDAQ:AVEO) RBC Capital Markets Jason Kantor Other Market outperform -19% $13.97 Kantor …
Published on 1/9/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/30 cls Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) Needham Alan Carr Upgrade Buy (from hold) -3% $8.54 Carr also set a $10 target…
Published on 1/2/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/16 cls BioSante Pharmaceuticals Inc. (NASDAQ:BPAX) Jefferies Graig Suvannavejh Downgrade Hold (from buy) -82% $0.45 Leerink …
Published on 12/19/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/9 cls Omeros Corp. (NASDAQ:OMER) Rodman Elemer Piros Upgrade Market outperform (from market perform) 3% $4.04 Piros also set a $13…
Published on 12/12/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/2 cls Anthera Pharmaceuticals Inc. (NASDAQ:ANTH) Wedbush Duane Nash Upgrade Market outperform (from neutral) 19% $6.48 Nash also …
Published on 12/5/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/18 cls Alimera Sciences Inc. (NASDAQ:ALIM) Cowen Simos Simeonidis Downgrade Neutral (from market outperform) $1.29 -34% Simeonidis…
Published on 11/21/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/11 cls Inhibitex Inc. (NASDAQ:INHX) Deutsche Bank Robyn Karnauskas Price target Buy 9% $9.29 Karnauskas raised her target to $15 …
Published on 11/14/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/4 cls Active Biotech AB (SSE:ACTI) Jefferies Peter Welford Downgrade Hold (from buy) -34% SEK19.40 Welford also lowered his target…
Published on 11/7/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/28 cls AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) Ladenburg Thalmann Juan Sanchez Upgrade Buy (from neutral) 8% $14.64 Sanchez …
Published on 10/31/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/21 cls Abbott Laboratories (NYSE:ABT) Credit Suisse Catherine Arnold Other Neutral 2% $53.86 Goldman Sachs Jami Rubin Price …
Published on 10/24/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/14 cls Acorda Therapeutics Inc. (NASDAQ:ACOR) Baird Christopher Price target Neutral 2% $21.75 Raymond Raymond lowered his target…
Published on 10/17/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/7 cls Biogen Idec Inc. (NASDAQ:BIIB) William Blair John Sonnier Upgrade Market outperform (from market perform) 7% $100.01 Sonnier…
Published on 10/10/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/30 cls Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) Leerink Howard Liang Price target Market outperform -3% $64.06 Liang raised his …
Published on 10/3/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/23 cls Basilea Pharmaceutica AG (SIX:BSLN) Jefferies Philippa Gardner Upgrade Hold (from underperform) 10% CHF34.50 Gardner …
Published on 9/26/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/16 cls Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) Leerink Joshua Schimmer Upgrade Market outperform (from market perform) 17% $7.48…
Published on 9/19/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/9 cls Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) Piper Jaffray Edward Tenthoff New Overweight 4% $5.81 Tenthoff set a $12 target …
Published on 9/12/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/2 cls Dendreon Corp. (NASDAQ:DNDN) Baird Christopher Raymond Price target Neutral -8% $10.96 Raymond lowered his target to $14 from…
Published on 9/5/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/26 cls Actelion Ltd. (SIX:ATLN) Jefferies Peter Welford Price target Hold 5% CHF32.50 Welford lowered his target to CHF32 from …
Published on 8/29/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/19 cls Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) Piper Jaffray Edward Tenthoff Upgrade Overweight (from neutral) -4% $6.62 …
Published on 8/22/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/12 cls Charles River Laboratories International Inc. (NYSE:CRL) Jefferies David Windley Price target Hold -6% $30.84 Windley …
Published on 8/15/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/5 cls Dendreon Corp. (NASDAQ:DNDN) Baird Christopher Raymond Downgrade Neutral (from buy) -66% $12.56 Brean Murray Jonathan …
Published on 8/8/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/29 cls Biogen Idec Inc. (NASDAQ:BIIB) Baird Christopher Raymond Price target Neutral -4% $101.87 Jefferies Thomas Wei Price …
Published on 8/1/2011